As big pharma exits Nigeria, asthma patients face spiralling costs
Price of asthma inhalers has more than doubled amid scarcity and added costs after GSK exited Nigerian market in 2023.
Price of asthma inhalers has more than doubled amid scarcity and added costs after GSK exited Nigerian market in 2023.